References
- Plotkin SL, Plotkin SA. A short history of vaccination. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia: WB Saunders Co, 2004:1-16.
- Chen RT, Markowitz LE, Albrecht P. Measles antibodies: re-evaluation of protective titers. J Infect Dis 1990;162:1036-62. https://doi.org/10.1093/infdis/162.5.1036
- Gustafson TL, Lievens AW, Brunell PA, Moellenberg RG, Buttery CM, Sehulster LM. Measles outbreak in a fully immunized secondary-school population. N Engl J Med. 1987;316:771-4. https://doi.org/10.1056/NEJM198703263161303
- Whittle HC, Aaby P, Samb B, Jensen H, Bennet J, Simondon F. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet 1999;353:98-102. https://doi.org/10.1016/S0140-6736(98)02364-2
- Mossong J, Muller CP. Modelling measles re-emergence as a result of waning of immunity in vaccinated population. Vaccine 2003:21:4597-603. https://doi.org/10.1016/S0264-410X(03)00449-3
- Mossong J, Nokes J, Edmunds DJ, Cox WJ, Ratman MJ, Muller CP. Modelling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am J Epidemiol 1999;150:1238-49. https://doi.org/10.1093/oxfordjournals.aje.a009951
- Rouderfer V, Becker NG, Hethcote HW. Waning immunity and its effect on vaccination schedules. Math Biosci 1994;124:59-82. https://doi.org/10.1016/0025-5564(94)90024-8
- Galazka AM, Robertson SE, Oblapenko GP. Resurgence of diphtheria. Eur J Epidemiol 1995;11:95-105. https://doi.org/10.1007/BF01719954
- Teitelbaum MA, Edmunds M. Immunization and vaccine-preventable illness, United States, 1992-1997. Stat Bull Metrop Insur Co 1999;80:13-20.
- Wright SW. Pertussis infection in adults. South Med J 1998;91:702-8.
- Whittle HC, Aaby P, Samb B, Jensen H, Bennet J, Simondon F. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet 1999;353:98-102. https://doi.org/10.1016/S0140-6736(98)02364-2
- Pelletier L, Chung P, Duclos P, Manga P, Scott J. A benefit-cost analysis of two dose measles immunization in Canada. Vaccine 1998;16:989-96. https://doi.org/10.1016/S0264-410X(97)00281-8
- Janaszek W, Gay NJ, Gut W. Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population in Poland. Vaccine 2003;21:473-8. https://doi.org/10.1016/S0264-410X(02)00482-6
- Wenger JD, Ward JI: Haemophilus influenzae vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia: WB Saunders Co, 2004:229-68.
- Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007;357:1903-15. https://doi.org/10.1056/NEJMoa066092
- Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 2001;20: 63-75. https://doi.org/10.1097/00006454-200101000-00013
- Plotkin S. Correlates of vaccine-induced immunity. Clin Infect Dis 2008;47:401. https://doi.org/10.1086/589862
- Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonski GA, Bernier RH. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J Infect Dis 1991;163:1-6. https://doi.org/10.1093/infdis/163.1.1
- Plotkin SA, Starr SE, Friedman HM, Gonczol E, Weibel RE. Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J Infect Dis 1989;159:860-5. https://doi.org/10.1093/infdis/159.5.860
- Taranger J, Trollfors B, Lagergard T, Sundh V, Bryla DA, Schneerson R, et al. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis 2000;181:1010-3. https://doi.org/10.1086/315318
- Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990;162: 1036-42. https://doi.org/10.1093/infdis/162.5.1036
- Permar SR, Klumpp SA, Mansfield KG, Kim WK, Gorgone DA, Lifton MA, et al. Role of CD8+ lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J Virol 2003;77:4396-400. https://doi.org/10.1128/JVI.77.7.4396-4400.2003
- Permar SR, Klumpp SA, Mansfield KG, Carville AA, Gorgone DA, Lifton MA, et al. Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. J Infect Dis 2004;190: 998-1005. https://doi.org/10.1086/422846
- Pan CH, Valsamakis A, Colella T, Nair N, Adams RJ, Polack FP, et al. Inaugural article: modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H encoding alphavirus replicon particles. Proc Natl Acad Sci USA 2005; 102:11581-8. https://doi.org/10.1073/pnas.0504592102
- Polack FP, Lee SH, Permar S, Manyara E, Nousari HG, Jeng Y, et al. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nat Med 2000;6:776-81. https://doi.org/10.1038/77506
- Plotkin SA. Vaccination against the major infectious diseases. C R Acad Sci III 1999;322:943-51. https://doi.org/10.1016/S0764-4469(00)87191-7
- Kobiler D, Weiss S, Levy H, Fisher M, Mechaly A, Pass A, et al. Protective antigen as a correlative marker for anthrax in animal models. Infect Immun 2006;74: 5871-6. https://doi.org/10.1128/IAI.00792-06
- Pitt ML, Little SF, Ivins BE, Fellows P, Barth J, Hewetson J, et al. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine 2001; 19:4768-73. https://doi.org/10.1016/S0264-410X(01)00234-1
- Reuveny S, White MD, Adar YY, Kafri Y, Altboum Z, Gozes Y, et al. Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun 2001;69:2888-93. https://doi.org/10.1128/IAI.69.5.2888-2893.2001
- Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg(Lond) 1972;70:767-77.
- Lee H, Nahm MH, Burton R, Kim KH. Immune response ininfants of the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A. Clin Vaccine Immunol 2009;16:376-81. https://doi.org/10.1128/CVI.00344-08
- Horstmann DM. Viral vaccines and their ways. Rev Infect Dis 1979;1:502-16. https://doi.org/10.1093/clinids/1.3.502
- Plotkin SA, Farquhar JD, Ogra PL. Immunologic properties of RA27-3 rubella virus vaccine: a comparison with strains presently licensed in the United States. JAMA 1973;225:585-90. https://doi.org/10.1001/jama.225.6.585